Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.
about
A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain sheddingCirculating tumor DNA: a promising biomarker in the liquid biopsy of cancerDetection of circulating tumor DNA in early- and late-stage human malignanciesMolecular Imaging of Pancreatic Cancer with Antibodies.Detection of pancreatic cancer with normal carbohydrate antigen 19-9 using protein chip technology.A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid ProfileIdentification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic AdenocarcinomaEarly Detection of Pancreatic Cancer-a Defined Future Using Lessons From Other Cancers: A White Paper.Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based ProteomicsThe Role of CA19-9 in Predicting Tumour Resectability in Carcinoma Head of PancreasValue of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first-line therapyPrognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma.Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancerBiomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy.An update on cancer risk and surveillance in primary sclerosing cholangitis.Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer.Distribution of circulating tumor DNA in lung cancer: analysis of the primary lung and bone marrow along with the pulmonary venous and peripheral blood.Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.Raised CA19.9 and hepatic space occupying lesion after teriparatide therapy in a case of polyostotic fibrous dysplasia.Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer.Detection of K-ras gene mutations in feces by magnetic nanoprobe in patients with pancreatic cancer: A preliminary study.Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.CA19-9-related tumor kinetics after first-line chemotherapy of patients with advanced pancreatic cancer: a monoinstitutional experience.Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging.Nomogram for predicting survival in patients with pancreatic cancer.Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer.Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.The outcome of cryoablation in treating advanced pancreatic cancer: a comparison with palliative bypass surgery alone.Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling.Multiplexed panel of precisely quantified salivary proteins for biomarker assessment.Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?Programmed cell death 6 interacting protein (PDCD6IP) and Rabenosyn-5 (ZFYVE20) are potential urinary biomarkers for upper gastrointestinal cancer.Immunosensor for Pancreatic Cancer Based on Electrospun Nanofibers Coated with Carbon Nanotubes or Gold Nanoparticles.Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer
P2860
Q21132301-9653DF3F-01E3-4C19-BE00-9F704AB7C618Q26746010-F41331B5-5ED6-4350-8DD0-C1D40DF8E277Q29615778-D62DD437-99D5-4C73-ABE2-380AB07E8911Q30393523-2F7C8A71-2616-4BF2-AD07-DF331C996DADQ34405197-B8DBA1A8-03D4-4397-8E5B-6FC077ECCACFQ35680475-210C3240-E6C6-46A2-8849-A0C1494F3F94Q35964357-D1FDB519-6E31-4A37-91C6-41EFD4C8E09EQ36102795-ADA67C5B-1E4C-4F17-AE90-01197487BB43Q36118351-21A9B89F-B0C8-4CE8-80E2-7F050F794227Q36831137-8B105E53-991B-4968-9155-8C1A10CCB9C8Q36927697-0E38F0C8-E598-4589-A28C-7216DE9FC4A9Q37367504-A1D151DD-C1AD-4052-88B1-A22444C8BA9BQ37565619-881C1451-E0C0-4F6C-AA83-B859BA864942Q38129331-027C8388-748D-42C4-AE2C-99B7AEC008EBQ38801235-A9108B3E-E1BC-4177-BF76-B3BA97B9D50CQ39060326-3EFF2C73-B543-4D6E-9C84-D705B745B7A3Q40495250-9428CDFC-EDFA-435B-B2BC-EF5F191CC7ECQ41708857-31EF11B4-982C-4BD8-B84E-D9C3F77FCCA4Q41766645-0903A39C-A296-47AF-B6D8-87B8D72F487CQ42695251-DE5D88AF-5478-4BA2-9034-D54C02F27788Q42966009-3CB51FCE-A984-4E17-9321-B4EF7D687D70Q47097183-E4BB46BA-1226-47BE-AD34-5DA1A21B83A2Q47100731-A3A589BB-63C5-4019-A924-BF01003B5C15Q47679320-85408A88-9089-4B39-A552-35301FDB6E0DQ48113448-0F21B625-5825-4903-8B6F-A0A51D66DFBDQ48149907-539FBCBC-CCEC-4410-BBEE-C78089B685A3Q49217510-24BEEA49-A310-4BC7-8095-9E097490D7AFQ50217905-652FD0A6-6CBA-4B69-854F-E254FF2C1BF7Q50536915-EDA6C4CE-B5C1-43BC-ABDA-EBE8008C3746Q50579768-60F904AD-D7FA-4304-9580-CEB9D12DA935Q50665689-8C7B1C46-0BFA-42D1-B586-92FB048693FCQ51298601-53AAE850-B9D7-44ED-9737-711301F4F692Q51564069-FE2129FA-8268-42C8-B3C6-D1AE5FA5942CQ52739894-00026C9F-A4D5-45BA-909F-21DD0A66B1B4Q52970611-47AE2574-B0B1-4C36-A6EF-6485450E7051Q55686939-E3F51BF9-E813-403C-91E4-2511AB0E0FFBQ58608805-F52822F6-2044-4471-9762-1030A3B462DB
P2860
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.
@en
type
label
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.
@en
prefLabel
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.
@en
P2860
P1476
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.
@en
P2093
Ronald S Chamberlain
Umashankar K Ballehaninna
P2860
P2888
P304
P356
10.1007/S13193-011-0042-1
P577
2011-02-17T00:00:00Z
P5875
P6179
1042064486